Currently Speaking

Current Consulting Group
  • 3,0 (2)
  • МЕНЕДЖМЕНТ
  • ЕЖЕДНЕВНО

The Current Consulting Group is uniquely qualified to meet its dual mission, which is to help employers comply with all applicable drug testing laws & regulations and to help employee screening providers increase revenue, improve profitability, & effectively promote their brand. The Current Consulting Group features a diverse team of employee screening subject matter experts & marketing specialists. Currently Speaking is a podcast designed to provide employers and providers with the latest employee screening trends, emerging technologies, and legal information, so that you can be Current too.

  1. 20 АПР.

    Currently Speaking on the Growing Role of Oral Fluid Testing, with Rod Weis of Premier Biotech

    This episode of Currently Speaking dives into why rapid-result oral fluid testing is gaining traction, how solutions like OralTox® and OT-Scan® are improving efficiency and compliance, and what these advancements mean for employers navigating today’s hiring challenges. The landscape of drug testing is rapidly evolving, and organizations must adapt to remain compliant and efficient. Rod Weis's insights provide a roadmap for leveraging instant oral fluid testing, embracing full-service providers, and utilizing technology to enhance drug testing processes. By implementing these strategies, organizations can not only streamline their drug testing procedures but also ensure accuracy and compliance.

    22 мин.

  2. 9 АПР.

    Currently Speaking on Workplace Drug Abuse: Too Scary to Ignore

    This episode of Currently Speaking explores the serious issue of workplace drug abuse, highlighting real incidents, the impact of drug testing, and the importance of maintaining safe, drug-free workplaces.

    12 мин.

  3. 18 МАР.

    Currently Speaking on Drug Testing, Impairment, and Marijuana: Your Questions Answered

    In this episode of Currently Speaking, Bill Current follows up on his recent Current in 30 webinar, Addressing Marijuana in Your Drug Testing Policy: Complacency Is Not an Option, by answering several important questions that employers frequently ask about marijuana and workplace drug testing. As marijuana legalization continues to expand across the United States, employers are facing new challenges when it comes to maintaining safe and compliant workplaces. In this short episode, Bill discusses whether employers can still test for marijuana in states where it is legal, how companies can address workplace impairment, the risks of removing marijuana from a drug testing panel, and how often drug testing policies should be reviewed and updated. Bill also explores the growing role of oral fluid testing and whether it can help identify more recent marijuana use compared to traditional urine testing. If you would like to watch the full webinar presentation, a link to the recording is included with this episode. https://youtu.be/-Nv6DTGmXLs

    17 мин.

  4. 3 МАР.

    Currently Speaking on Legalizing Marijuana: Is It Time to Acknowledge Reality and Change Course?

    In this episode of Currently Speaking, Bill Current discusses the evolving conversation around marijuana legalization, particularly in light of a recent editorial from the New York Times that acknowledges the negative consequences of looser marijuana policies. The discussion covers the implications of marijuana reclassification, the rise in usage and addiction, and the impact on workplace safety. Current emphasizes the need for employers to take a firm stance on marijuana use in the workplace, especially as the cannabis industry continues to grow and the realities of marijuana's effects become more apparent.

    13 мин.

  5. 17 ФЕВР.

    Currently Speaking on Would Marijuana Rescheduling Affect Drug Testing in 2026

    President Trump’s recent Executive Order to reclassify marijuana from a Schedule I to a Schedule III drug under the Drug Enforcement Administration has sparked debate about the future of workplace drug testing. Schedule I drugs are defined as having no accepted medical use and a high potential for abuse, while Schedule III drugs are considered to have a lower potential for dependence.Despite possible reclassification, most employers conduct drug testing primarily to promote workplace safety — the top reason cited in Current Consulting Group’s 2025 employer survey. Employers also report improved employee quality, reduced legal risks, and enhanced productivity as key benefits. Research showing high rates of on-the-job marijuana use, along with increased workers’ compensation claims in states with recreational marijuana laws, reinforces employer concerns about impairment and safety.Listen to the latest episode of Currently Speaking to learn more about how rescheduling marijuana will impact drug testing in 2026.

    13 мин.

  6. 21 ЯНВ.

    Currently Speaking on FAA Foreign Repair Stations & Drug and Alcohol Testing

    In Part 2 of this conversation, Bill Current and Greg Henderson dive into the FAA foreign repair station drug and alcohol testing ruling, what it requires, and why employers should act now ahead of the 2027 enforcement deadline. The discussion covers compliance timelines, waiver challenges, safety considerations, and how marijuana rescheduling may intersect with FAA testing requirements.

    20 мин.

  7. 21 ЯНВ.

    Currently Speaking on Marijuana Rescheduling & Workplace Drug Testing

    The conversation around marijuana rescheduling is heating up! In this podcast episode, part 1 of a 2-part series, Bill Current, founder of Current Consulting Group, and Greg Henderson, founder of Federal Drug Testing Services, dive into marijuana rescheduling, common compliance misconceptions, and what employers need to know about workplace drug testing regulations. The discussion focuses on safety, federal oversight, and why current testing requirements remain in place. Don't let misinformation steer your decisions! What questions do you have about compliance and safety in this evolving landscape? Let's chat!

    23 мин.

  8. 6 ЯНВ.

    Currently Speaking on What Can We Learn About Marijuana & Drug Testing from Current Consulting Group’s Annual Employer Survey?

    As more employers remove marijuana from drug-testing panels, is it a costly mistake? According to Current Consulting Group’s 2025 Employer Drug Testing Survey, fewer companies are testing for cannabis—despite warnings from medical expert Dr. Marc Siegel, who calls marijuana “the most dangerous drug in America.” In this episode of Currently Speaking, the podcast of the Current Consulting Group, we examine why marijuana is being normalized, the myths around its safety and medicinal value, and what employers may be overlooking about its real risks. A must-listen for business leaders, HR professionals, and anyone questioning whether weed is truly harmless.

    15 мин.
См. все (68)

Оценки и отзывы

3
из 5
Оценок: 2

Об этом подкасте

The Current Consulting Group is uniquely qualified to meet its dual mission, which is to help employers comply with all applicable drug testing laws & regulations and to help employee screening providers increase revenue, improve profitability, & effectively promote their brand. The Current Consulting Group features a diverse team of employee screening subject matter experts & marketing specialists. Currently Speaking is a podcast designed to provide employers and providers with the latest employee screening trends, emerging technologies, and legal information, so that you can be Current too.

Информация

  • Автор
    Current Consulting Group
  • Годы выхода
    2024 - 2026
  • Выпуски
    68
  • Ограничения
    Без ненормативной лексики
  • Авторские права
    © Current Consulting Group
  • Сайт подкаста
    Currently Speaking